日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Development of a prognostic scoring system for chronic myeloid leukemia in blast phase

慢性粒细胞白血病急变期预后评分系统的建立

Lauseker, Michael; Sacha, Tomasz; Klamova, Hana; Yakoleva, Julia; Lomaia, Elza; Milojkovic, Dragana; Fabisch, Christian; Nicolini, Franck E; Olsson-Stromberg, Ulla; Zackova, Daniela; Lewandowski, Krzysztof; Ernst, Philipp; Castagnetti, Fausto; Hirschbühl, Klaus; Zupan, Irena; Voskanyan, Astghik; Gołos, Aleksandra; Frietsch, Jochen J; Gil, Justyna; Faber, Edgar; Krause, Stefan W; Parry, Anne; Saussele, Susanne; Heibl, Sonja; Franke, Georg-Nikolaus; Casado, Luis Felipe; Paczkowska, Edyta; Hebart, Holger; Eder, Matthias; Anhut, Peter; Trautmann-Grill, Karolin; Szczepanek, Elzbieta; Südhoff, Thomas; Patkowska, Elzbieta; Kiani, Alexander; Ernst, Thomas; Apperley, Jane; Mayer, Jiri; Hochhaus, Andreas; Pfirrmann, Markus; Brioli, Annamaria

Acceleration-Ejection Time Ratio in Patients With Severe Classic Low-Flow Low-Gradient Aortic Stenosis

重度经典低流量低梯度主动脉瓣狭窄患者的加速射血时间比

Layoun, Habib; Lomaia, Tamari; Besir, Besir; Hajj, Joseph; Rajendran, Judah; Badwan, Osamah; Reed, Grant W; Krishnaswamy, Amar; Harb, Serge; Kapadia, Samir

Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib: A Phase 1b Randomized Clinical Trial

奥维瑞巴替尼用于酪氨酸激酶抑制剂(包括帕纳替尼或阿西米尼)治疗失败后的疗效:一项 1b 期随机临床试验

Jabbour, Elias; Oehler, Vivian G; Koller, Paul B; Jamy, Omer; Lomaia, Elza; Hunter, Anthony M; Uspenskaya, Olga; Samarina, Svetlana; Mukherjee, Sudipto; Cortes, Jorge E; Baer, Maria R; Zherebtsova, Vera; Shuvaev, Vasily; Turkina, Anna; Davydkin, Igor; Guo, Huanshan; Chen, Zi; Fu, Tommy; Jiang, Lixin; Wang, Cunlin; Wang, Hengbang; Yang, Dajun; Zhai, Yifan; Kantarjian, Hagop

Asciminib remained superior vs bosutinib in late-line CML-CP after nearly 4 years of follow-up in ASCEMBL

在ASCEMBL研究中,经过近4年的随访,阿西米尼在晚期慢性粒细胞白血病慢性期(CML-CP)治疗中仍优于博舒替尼。

Mauro, Michael J; Minami, Yosuke; Hochhaus, Andreas; Lomaia, Elza; Voloshin, Sergey; Turkina, Anna; Kim, Dong-Wook; Apperley, Jane F; Cortes, Jorge E; Abdo, Andre; Fogliatto, Laura Maria; Kim, Dennis Dong Hwan; le Coutre, Philipp; Saussele, Susanne; Annunziata, Mario; Hughes, Timothy P; Chaudhri, Naeem; Chee, Lynette; García-Gutiérrez, Valentin; Sasaki, Koji; Boquimpani, Carla; Kapoor, Shruti; Espurz, Noemi; Dhamal, Vishal; Rea, Delphine

Long-Term Outcomes of Mild Paravalvular Leak Following Transcatheter Aortic Valve Replacement

经导管主动脉瓣置换术后轻度瓣周漏的长期预后

Rosenzveig, Akiva; Ramu, Shivabalan Kathavarayan; Besir, Besir; Lomaia, Tamari; Rajendran, Judah; Badwan, Osamah; Agrawal, Ankit; Reed, Grant; Yun, James; Puri, Rishi; Krishnaswamy, Amar; Kapadia, Samir R

Outcomes of Patients With a Small and Large Aortic Annulus Following Balloon-Expandable Transcatheter Aortic Valve Replacement Across Flow-Gradient Patterns

不同血流梯度模式下,主动脉瓣环大小不同的患者接受球囊扩张式经导管主动脉瓣置换术后的预后

Besir, Besir; Ramu, Shivabalan Kathavarayan; Lomaia, Tamari; Ali Majeed-Saidan, Maryam Muhammad; Rajendran, Judah; Motairek, Issam; Harb, Serge C; Miyasaka, Rhonda; Reed, Grant W; Puri, Rishi; Yun, James J Y; Krishnaswamy, Amar; Kapadia, Samir R

Phase-1 study of vamotinib (PF-114), a 3rd generation BCR::ABL1 tyrosine kinase-inhibitor, in chronic myeloid leukaemia

一项针对慢性粒细胞白血病患者的I期研究,评估了第三代BCR::ABL1酪氨酸激酶抑制剂vamotinib (PF-114)的疗效。

Turkina, Anna; Vinogradova, Olga; Lomaia, Elza; Shatokhina, Evgeniya; Shukhov, Oleg; Chelysheva, Ekaterina; Shikhbabaeva, Dzhariyat; Nemchenko, Irina; Petrova, Anna; Bykova, Anastasiya; Siordiya, Nadiya; Shuvaev, Vasily; Mikhailov, Ilya; Novikov, Fedor; Shulgina, Veronika; Hochhaus, Andreas; Ottmann, Oliver; Cortes, Jorge; Gale, Robert Peter; Chilov, Ghermes

The Emergence of a Novel Insertional Mutation in the BCR::ABL/p210 Oncogene in B-Cell Acute Lymphoblastic Leukemia (B-ALL) Correlates with the Development of Resistance to Several Tyrosine Kinase Inhibitors

B细胞急性淋巴细胞白血病(B-ALL)中BCR::ABL/p210癌基因新插入突变的出现与对多种酪氨酸激酶抑制剂产生耐药性相关

Bogdanov, K V; Kudryavtseva, E S; Lobacheva, Y N; Merzlikina, O V; Mirolyubova, Y V; Vlasik, R A; Badaev, R Sh; Lomaia, E G

Outcomes and Predictors of Flow Improvement After Transcatheter Aortic Valve Replacement in Patients With Low-Flow Low-Gradient Aortic Stenosis

低流量低梯度主动脉瓣狭窄患者经导管主动脉瓣置换术后血流改善的结果和预测因素

Besir, Besir; Ali Majeed-Saidan, Maryam Muhammad; Ramu, Shivabalan Kathavarayan; Lomaia, Tamari; Rajendran, Judah; Iskandar, Odette; Motairek, Issam; Harb, Serge C; Miyasaka, Rhonda; Yun, James; Puri, Rishi; Reed, Grant W; Krishnaswamy, Amar; Kapadia, Samir R

Asciminib add-on to imatinib demonstrates sustained high rates of ongoing therapy and deep molecular responses with prolonged follow-up in the ASC4MORE study

在 ASC4MORE 研究中,Asciminib 与伊马替尼联合用药显示出持续高水平的治疗效果和深度分子学缓解,且随访时间延长。

Hughes, Timothy P; Saglio, Giuseppe; Geissler, Jan; Kim, Dong-Wook; Lomaia, Elza; Mayer, Jiri; Turkina, Anna; Kapoor, Shruti; Cardoso, Ana Paula; Nieman, Becki; Quenet, Sara; Cortes, Jorge E